Document:

EX-10.2

 Exhibit 10.2 
 BUYER STOCKHOLDER AGREEMENT 
 This Stockholder Agreement (this
“Agreement”), dated as of March 17, 2013, is entered into by and between Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”), and the undersigned stockholder (“Stockholder”) of Cynosure,
Inc., a Delaware corporation (the “Buyer”). 
 WHEREAS, concurrently with the execution of this Agreement, the
Company, the Buyer and Commander Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of the Buyer (the “Merger Subsidiary”), are entering into an Agreement and Plan of Merger (as the same may be amended from time to
time, the “Merger Agreement”), providing for, among other things, the merger (the “Merger”) of the Merger Subsidiary and the Company pursuant to the terms, and subject to the conditions, of the Merger Agreement; 

WHEREAS, as a condition to its willingness to enter into the Merger Agreement, the Company has required that Stockholder execute and
deliver this Agreement; and 
 WHEREAS, in order to induce the Company to enter into the Merger Agreement, Stockholder is
willing to make certain representations, warranties, covenants and agreements with respect to the shares of Class A common stock, par value $0.001 per share, of the Buyer (the “Buyer Common Stock”) owned beneficially and of record by
Stockholder, as set forth below Stockholder’s signature on the signature page hereto (the “Original Shares” and, together with any additional shares of Buyer Common Stock pursuant to Section 6 hereof, the “Shares”).

 NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt, sufficiency and
adequacy of which are hereby acknowledged, the parties hereto agree as follows: 
  

	1.	Definitions. 

 For
purposes of this Agreement, capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to them in the Merger Agreement. 
  

	2.	Representations of Stockholder. 

 Stockholder represents and warrants to the Company that: 
 (a) (i)
Stockholder owns beneficially and of record all of the Original Shares free and clear of all Liens, except for any such Lien that, individually or in the aggregate, would not reasonably be expected to affect adversely the ability of Stockholder to
perform its obligations 

 
under this Agreement, and has the sole right to vote (or cause to be voted) the Original Shares, and (ii) except pursuant hereto, there are no options, warrants or other rights, agreements,
arrangements or commitments of any character to which Stockholder is a party relating to the pledge, disposition or voting of any of the Original Shares and there are no voting trusts or voting agreements with respect to the Original Shares.

 (b) Stockholder does not own beneficially or of record any shares of Buyer Common Stock other than (i) the Original
Shares and (ii) any options, warrants or other rights to acquire any additional shares of Buyer Common Stock or any security exercisable for or convertible into shares of Buyer Common Stock, as set forth on the signature page of this Agreement
(collectively, the “Options”). 
 (c) Stockholder has full corporate (or comparable) power and authority (if an
entity) or the legal capacity (if a natural person) to enter into, execute and deliver this Agreement, to perform fully Stockholder’s obligations hereunder (including the proxy described in Section 3(b) below) and to consummate the
transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Stockholder and constitutes the valid and binding obligation of Stockholder, enforceable against Stockholder in accordance with its terms, subject
to the Bankruptcy and Equity Exceptions. 
 (d) None of the execution and delivery of this Agreement by Stockholder, the
consummation by Stockholder of the transactions contemplated hereby or compliance by Stockholder with any of the provisions hereof will conflict with or result in a breach, or constitute a default (with or without notice or lapse of time or both)
under any provision of, any trust agreement, loan or credit agreement, note, bond, mortgage, indenture, lease or other agreement, instrument or law applicable to Stockholder or to Stockholder’s property or assets, except for any such conflict
or breach that (i) has been waived or cured prior to the date hereof or (ii) individually or in the aggregate, would not reasonably be expected to affect adversely the ability of Stockholder to perform Stockholder’s obligations under
this Agreement. 
 (e) No consent, approval or authorization of, or designation, declaration or filing with, any Governmental
Entity or other person on the part of Stockholder is required in connection with the valid execution and delivery of this Agreement, except for any such consent, approval, authorization, designation, declaration or filing that (i) has been
obtained or made (as applicable) prior to the execution and delivery hereof or (ii) if not obtained or made (as applicable), individually or in the aggregate, would not reasonably be expected to affect adversely the ability of Stockholder to
perform Stockholder’s obligations under this Agreement. To the extent Stockholder is a natural person, no consent of Stockholder’s spouse is necessary under any “community property” or other laws in order for Stockholder to enter
into and perform its obligations under this Agreement, except for any such consent that (A) has been obtained prior to the execution and delivery hereof or (B) if not obtained, individually or in the aggregate, would not reasonably be
expected to affect adversely the ability of Stockholder to perform Stockholder’s obligations under this Agreement. 

  
 2 

	3.	Agreement to Vote Shares; Irrevocable Proxy. 

 (a) Stockholder hereby irrevocably and unconditionally agrees, from and after the date hereof and until the Termination Date, to vote the Shares (or execute a written consent or consents if stockholders
of the Buyer are requested to vote their shares through the execution of an action by written consent in lieu of any such annual or special meeting of stockholders of the Buyer) and to cause any holder of record of Shares to vote such Shares (or
execute such written consents): (i) in favor of the Buyer Voting Proposal and the Buyer Equity Plan Proposal; and (ii) against any action, proposal, transaction or agreement which would reasonably be expected to result in a breach of any
covenant, representation or warranty or any other obligation or agreement of the Buyer under the Merger Agreement or of Stockholder under this Agreement. Except as set forth in this Section 3, Stockholder shall not be restricted from voting in
favor of, against or abstaining with respect to any matter presented to the stockholders of the Buyer. 
 (b) Stockholder hereby
appoints the Company and any designee of the Company, and each of them individually, its proxies and attorneys-in-fact, with full power of substitution and resubstitution, to vote or act by written consent during the term of this Agreement with
respect to the Shares in accordance with Section 3(a). This proxy and power of attorney is given to secure the performance of the duties of Stockholder under this Agreement. Stockholder shall take such further action or execute such other
instruments as may be necessary to effectuate the intent of this proxy. This proxy and power of attorney granted by Stockholder shall be irrevocable during the term of this Agreement, shall be deemed to be coupled with an interest sufficient in law
to support an irrevocable proxy and shall revoke any and all prior proxies granted by Stockholder with respect to the Shares. The power of attorney granted by Stockholder herein is a durable power of attorney and shall survive the dissolution,
bankruptcy, death or incapacity of Stockholder. The proxy and power of attorney granted hereunder shall terminate upon the termination of this Agreement. 
  

	4.	No Voting Trusts or Other Arrangement. 

 Stockholder agrees that Stockholder will not, and will not permit any entity under Stockholder’s control to, deposit any of the Shares in a voting trust, grant any proxies with respect to the Shares
or subject any of the Shares to any arrangement with respect to the voting of the Shares, other than (a) agreements entered into with the Company or any of its Affiliates (which, for purposes of this Agreement, shall have the meaning set forth
in Rule 405 promulgated under the Securities Act) and (b) the granting of a proxy or proxies to vote the Shares on any matter (except for the matters described in clauses (i) and (ii) of Section 3(a) above) at any annual meeting
of the Buyer’s stockholders. 
  

	5.	Transfer and Encumbrance. 

Stockholder agrees that during the term of this Agreement, Stockholder will not, directly or indirectly, transfer, sell, offer, exchange,
assign, pledge or otherwise dispose of or encumber 

  
 3 

 
(“Transfer”) any of the Shares or enter into any contract, option or other agreement with respect to, or consent to, a Transfer of, any of the Shares or Stockholder’s voting or
economic interest therein. Any attempted Transfer of Shares or any interest therein in violation of this Section 5 shall be null and void. Notwithstanding anything to the contrary in this Agreement, this Section 5 shall not prohibit a
Transfer of the Shares by Stockholder (a) if Stockholder is a natural person, to any person who is a family member of Stockholder (as the term “family member” is defined by Form S-8 promulgated under the Securities Act (or any
successor or comparable form)) or upon the death of Stockholder, (b) pursuant to any written trading plan in effect on the date of this Agreement intended to satisfy the requirements of Rule 10b5-1 under the Exchange Act, (c) to an
Affiliate of Stockholder, or (d) after the record date for determining the stockholders eligible to vote at the Buyer Meeting, as set forth in the Joint Proxy Statement/Prospectus; provided, that a Transfer referred to in clauses (a) and
(c) of this sentence shall be permitted only if, as a precondition to such Transfer, the transferee agrees in writing to be bound by all of the terms of this Agreement. 

 

	6.	Additional Shares. 

Stockholder agrees that all shares of Buyer Common Stock that Stockholder purchases, acquires the right to vote or otherwise acquires
ownership beneficially or of record (excluding shares of Buyer Common Stock underlying unexercised or unvested Options) of after the execution of this Agreement shall be subject to the terms of this Agreement and shall constitute Shares for all
purposes of this Agreement. 
  

	7.	Termination. 

 This
Agreement shall terminate upon the earliest to occur of (a) the Effective Time, (b) September 30, 2013, and (c) the date on which the Merger Agreement is terminated in accordance with its terms (any such date described in the
foregoing clauses (a), (b) or (c) shall be referred to herein as the “Termination Date”). 
  

	8.	No Agreement as Director or Officer. 

 This Agreement is being entered into by Stockholder solely in Stockholder’s capacity as the beneficial and record owner of the Shares. Stockholder makes no agreement or understanding in this
Agreement in Stockholder’s capacity as a director or officer of the Buyer or any of its subsidiaries (if Stockholder holds such office), and nothing in this Agreement: (a) will limit or affect any actions or omissions taken by Stockholder
in stockholder’s capacity as such a director or officer, including in exercising rights under the Merger Agreement, and no such actions or omissions shall be deemed a breach of this Agreement or (b) will be construed to prohibit, limit or
restrict Stockholder from exercising Stockholder’s fiduciary duties as an officer or director to the Buyer or its stockholders. 

  
 4 

	9.	Specific Performance. 

Each party hereto acknowledges that it will be impossible to measure in money the damage to the non-breaching party if a party hereto
fails to comply with any of the obligations imposed by this Agreement, that every such obligation is material and that, in the event of any such failure, the non-breaching party will not have an adequate remedy at law or damages. Accordingly, each
party hereto agrees that the parties hereto shall be entitled to seek the remedy of specific performance of the terms hereof, in addition to any other remedy at law or in equity. 

 

	10.	Entire Agreement; Amendment. 

 This Agreement constitutes the entire agreement between the parties to this Agreement and supersedes any prior understandings, agreements or representations by or between the parties hereto, or any of
them, written or oral, with respect to the subject matter hereof, and the parties hereto specifically disclaim reliance on any such prior understandings, agreements or representations to the extent not embodied in this Agreement. This Agreement may
not be amended or supplemented, and no provisions hereof may be modified or waived, except by an instrument in writing signed by both parties hereto. No waiver of any provision hereof by either party shall be deemed a waiver of any other provision
hereof by such party, nor shall any such waiver be deemed a continuing waiver of any provision hereof by such party. 
  

	11.	Notices. 

 All notices and
other communications hereunder shall be in writing and shall be deemed duly delivered if delivered personally (notice deemed given upon receipt), sent via facsimile or e-mail or sent by a nationally recognized overnight courier service (notice
deemed given upon the receipt of proof of delivery), in each case to the intended recipient as set forth below: 
 If to the
Company: 
 Palomar Medical Technologies, Inc. 
 15 Network Drive 
 Burlington, MA 01803 

Attention: Patricia A. Davis 
 Email: pdavis@palomarmedical.com 
 with a copy (which shall not constitute notice)
to: 
 Wilmer Cutler Pickering Hale and Dorr LLP 
 60 State Street 
 Boston, MA 02109 

Attention: Hal J. Leibowitz 
 Telecopy: (617) 526-5000 
 Email: hal.leibowitz@wilmerhale.com 

  
 5 

 If to Stockholder, to the address or email address set forth for Stockholder on the
signature page hereof. 
 with a copy (which shall not constitute notice) to: 

Hinckley, Allen & Snyder LLP 
 28 State Street 
 Boston, MA 02109 

Attention: James R. Burke 
 Telecopy: (617) 378-4347 
 Email: jburke@haslaw.com 

Either party to this Agreement may give any notice or other communication hereunder using any other means (including messenger service,
telecopy, telex or ordinary mail), but no such notice or other communication shall be deemed to have been duly given unless and until it actually is received by the party for whom it is intended. Either party to this Agreement may change the address
to which notices and other communications hereunder are to be delivered by giving the other party to this Agreement notice in the manner herein set forth. 
  

	12.	Miscellaneous. 

 (a) This
Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that
would cause the application of laws of any jurisdiction other than those of the State of Delaware. 
 (b) Each of the parties to
this Agreement (i) agrees that all actions and proceedings arising out of or relating to this Agreement or any of the transactions contemplated by this Agreement shall be heard and determined in the Chancery Court of the State of Delaware and
any state appellate court therefrom within the State of Delaware (or, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter, any federal court within Wilmington, Delaware), (ii) irrevocably
consents to submit itself to the exclusive jurisdiction and venue of such courts in any action or proceeding, (iii) agrees that all claims in respect of such action or proceeding shall be heard and determined in any such court, (iv) agrees
that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, and (v) agrees not to bring any action or proceeding arising out of or relating to this Agreement or any of the
transactions contemplated by this Agreement in any other court. Each of the parties hereto waives any defense of inconvenient forum to the maintenance of any action or proceeding so brought and waives any bond, surety or other security that might be
required of any other party with respect thereto. Either party hereto may make service on another party by sending or delivering a copy of the process to the party to be served at the address and in the manner provided for the giving of notices in
Section 11. Nothing in this Section 12(b), however, shall affect the right of either party to serve legal process in any other manner permitted by law. 

  
 6 

 (c) EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF EITHER PARTY HERETO IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND
ENFORCEMENT OF THIS AGREEMENT. 
 (d) Any term or provision of this Agreement that is invalid or unenforceable in any situation
in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If the final
judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, the parties hereto agree that the court making such determination shall have the power to limit the term or provision, to delete
specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and
this Agreement shall be enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable term or provision with a valid and
enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term. 
 (e) This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each of the parties hereto and delivered to the other party, it being understood that both parties need not sign the same counterpart. This Agreement may be executed and delivered by facsimile
transmission or as a “pdf” or similar attachment to an electronic transmission. 
 (f) All Section headings herein are
for convenience of reference only and are not part of this Agreement, and no construction or reference shall be derived therefrom. 
 (g) The obligations of Stockholder set forth in this Agreement shall not be effective or binding upon Stockholder until after such time as the Merger Agreement is executed and delivered by the Company,
the Buyer and Merger Subsidiary. The parties agree that there is not and has not been any other agreement, arrangement or understanding between the parties hereto with respect to the matters set forth herein. 

(h) Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned or delegated, in whole or
in part, by operation of law or otherwise by either of the parties hereto without the prior written consent of the other party, and any such 

  
 7 

 
assignment without such prior written consent shall be null and void. Subject to the preceding sentence, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by, the
parties hereto and their respective successors and permitted assigns. 
 [SIGNATURE PAGE FOLLOWS] 

  
 8 

 IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the date first
written above. 
  

			
	PALOMAR MEDICAL TECHNOLOGIES, INC.
		
	By	 	  

	Name:	 	
	Title:	 	

  

			
	STOCKHOLDER
		
	By	 	  

	Name:	 	
	
	 Number of Shares of Buyer Common Stock Owned Beneficially and of Record as of the Date of this Agreement:

 
 Number of Options Owned Beneficially and of Record as of the Date of this
Agreement:
  
 Street Address:

City/State/Zip Code:
 Email:

  
 9EX-10.3

 Exhibit 10.3 
 THIRD AMENDMENT TO 
 EMPLOYMENT AGREEMENT 

This shall serve as the Third Amendment to the Employment Agreement (this “Amendment”) entered into as of this 17 day of
March, 2013, between Palomar Medical Technologies, Inc., a Delaware corporation (the “Company”), and Joseph P. Caruso, an individual (the “Executive”). 

WHEREAS, the Company and the Executive are parties to a certain Employment Agreement, dated as of July 1, 2001, as amended as of
May 19, 2010 and further amended as of May 15, 2012 (the “Original Agreement”); 
 WHEREAS, the
Company and the Executive have agreed to amend the Original Agreement as set forth in this Amendment; 
 WHEREAS, the Company,
Cynosure, Inc., a Delaware corporation (the “Buyer”), and Commander Acquisition Corp., a Delaware corporation and wholly owned subsidiary of the Buyer (the “Merger Subsidiary”), intend to enter into an Agreement and
Plan of Merger (as the same may be amended from time to time, the “Merger Agreement”), providing for, among other things, the merger of the Company with and into the Merger Subsidiary (the “Merger”); and 

WHEREAS, as a condition to its willingness to enter into the Merger Agreement, the Buyer has required that the Company and the Executive
execute and deliver this Amendment and also a new employment agreement (the “New Agreement”), each of which is subject to the consummation of the Merger and shall become effective upon the Effective Time (as such term is defined in
the Merger Agreement) of the Merger. 
 NOW, therefore, the Company and the Executive agree to amend the Original Agreement as
follows: 
  

	 	1.	Section 1 is amended by adding the following language to the end of Section 1: 

“Notwithstanding the foregoing or anything else herein to the contrary, except to the extent necessary to implement the provisions of
Section 31 below, Sections 1 through 11 of this Agreement shall terminate effective upon the Effective Time, it being the intention of the parties that the New Agreement shall govern Executive’s employment on and after the Effective Time,
except as specifically provided herein.” 
  

	 	2.	Section 31 is hereby added to read as follows: 

 “31. Retention Bonus. 

 Subject to Section 30, within ten (10) days from the Effective Time, the Company
shall pay Executive, in a lump sum, an amount equal to seventy-five percent (75%) of the Retention Bonus. Subject to Section 30, and provided that either (i) the Executive is still employed by the Company as of the 35% Payment Date or
(ii) the Executive’s employment has terminated prior to the 35% Payment Date on account of his death pursuant to Section 7, disability pursuant to Section 8, termination by the Company without Cause, or resignation by the
Executive for Good Reason pursuant to Section 9, then the Company shall pay Executive, in a lump sum on the 35% Payment Date, an amount equal to thirty-five percent (35%) of the Retention Bonus. The “35% Payment Date” is the date
one day prior to the one-year anniversary of the Effective Time, provided that if such date is not a business day, then the 35% Payment Date shall be the most recent business day preceding the one-year anniversary of the Effective Time. 

For purposes of this Agreement, the term “Executive’s Annual Compensation” shall mean the sum of (A) the
Executive’s annual salary as of the Effective Time and (B) the Executive’s last paid bonus prior to the execution of this Amendment as “last paid bonus” has been defined by the Compensation Committee of the Company, that
being the last regular annual bonus paid in March of 2012 for services rendered to the Company during calendar year 2011. 
 For
purposes of this Agreement, the term “Retention Bonus” shall mean the amount equal to the sum of (A) three times (3x) the Executive’s Annual Compensation, and (B) a pro rata portion of the bonus payable with respect to
2013.” 
  

	 	3.	 The Company hereby covenants that this Amendment constitutes a termination of those portions of the Original Agreement to the extent providing for
nonqualified deferred compensation for purposes of Section 490A of the Internal Revenue Code, and is intended to comply with, and does comply with the provisions of Treasury Regulation Section 1.409A-3(j)(4)(ix)(B) and that such parties
will take all efforts to ensure that the requirements of such Treasury Regulation continue to be satisfied after the date hereof. If, notwithstanding the foregoing, any payment made or to be made under the Agreement, as amended, that constitutes
nonqualified deferred compensation within the meaning of Section 409A of the Internal Revenue Code (the “Payments”), is determined to be subject to the tax imposed by Section 409A(a)(1)(B) or any interest or penalties with
respect to such taxes (such taxes, together with any such interest and penalties, are collectively referred to as the “Section 409A Tax”), then upon assessment of such Section 409A Tax (including by reason of the
Executive’s filing of a return showing such Section 409A Tax due), then the Company will promptly pay to the 

	 	
Executive an additional amount (a “Gross-Up Payment”) such that the net amount the Executive retains after paying any applicable Section 409A Tax and any federal, state or
local income or FICA taxes on such Gross-Up Payment (“Gross-Up Payment Taxes”)shall be equal to the amount the Executive would have received if the Section 409A Tax had not been assessed. All determinations of the Gross-Up
Payment, if any, will be made by tax counsel or other tax advisers designated by or acceptable to the Executive. For purposes of determining the amount of the Gross-Up Payment Taxes, if any, the Executive will be deemed to pay federal income tax at
the highest marginal rate of federal income taxation in the calendar year in which the Payments are made and state and local income taxes at the highest marginal rate of taxation in the state and locality of the Executive’s residence on the
date the Payments are made, net of the maximum reduction in federal income taxes that could be obtained from deduction of such state and local taxes. Any Gross-Up Payment will be made no later than 30 days before such tax is payable by the Executive
to the Internal Revenue Service, provided that the Company shall not be required to make any Gross-Up Payment upon less than 5 business days written notice of the assessment of the Section 409A tax. If the Section 409A Tax is determined by
the Internal Revenue Service, on audit or otherwise, to exceed the amount taken into account hereunder in calculating the Gross-Up Payment (including by reason of any payment the existence or amount of which cannot be determined at the time of the
Gross-Up Payment), the Company must make another Gross-Up Payment with respect to such excess (plus any interest, penalties or additions payable by the Executive with respect to such excess) within ten (10) calendar days immediately following
the date that the amount of such excess is finally determined, provided that the Company shall not be required to make any such additional Gross-Up Payment upon less than 5 business days written notice of such final determination. The Company and
the Executive must each reasonably cooperate with the other in connection with any administrative or judicial proceedings concerning the existence or amount of liability for Section 409A Tax with respect to the total Payments.

  

	 	4.	The following shall be added as a new subsection (d) to Section 30 of the Agreement, as amended: 

“(d) All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the
requirements of Section 409A of the Code to the extent that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable, the requirements that (i) any reimbursement is for expenses incurred during
the Executive’s lifetime (or during a shorter period of time specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other
calendar year, (iii) the reimbursement of an eligible expense will be made on or before 

 
the last day of the calendar year following the year in which the expense is incurred and (iv) the right to reimbursement is not subject to set off or liquidation or exchange for any other
benefit.” 
  

	 	5.	As amended hereby, the term of the Original Agreement shall expire on the 35% Payment Date. For the avoidance of doubt, the Original Agreement and not the New Agreement
shall apply to payments made or due under the Original Agreement. This Amendment is subject to the consummation of the Merger and shall become effective as of the Effective Time of the Merger. For avoidance of doubt, if the Merger is not consummated
within the time period specified within the Merger Agreement, the Original Agreement shall remain in full force and effect. 

  

	 	6.	This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which together shall be considered one
instrument. 

  

	 	7.	This Amendment shall be construed in accordance with, and governed by the laws of, the Commonwealth of Massachusetts. 

[Signatures Appear On The Following Page] 

 IN WITNESS WHEREOF, the parties have executed this Amendment on the date first written above. 

 

					
	PALOMAR MEDICAL TECHNOLOGIES, INC.
		
	By	 	 /s/ Paul S. Weiner

		 	Name:	 	Paul S. Weiner
		 	Title:	 	Chief Financial Officer
	
	EXECUTIVE
		
		 	 /s/ Joseph P. Caruso

		 	Joseph P. Caruso

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]